Varian Medical Systems, Inc.:戦略・SWOT・企業財務分析

◆英語タイトル:Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015249
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Varian Medical Systems, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Varian Medical Systems, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Varian Medical Systems (Varian or ‘the company’) is a leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company operates in North America, Europe, Middle East, Africa) and Asia. Varian is headquartered in Palo Alto, California.

Scope

- Detailed information on Varian Medical Systems, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Varian Medical Systems, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Varian Medical Systems, Inc. including a breakdown and examination of key business segments
- Intelligence on Varian Medical Systems, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Varian Medical Systems, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Varian Medical Systems, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Varian Medical Systems, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Varian Medical Systems, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Varian Medical Systems, Inc.: Company Overview
Varian Medical Systems, Inc.: Overview and Key Facts
Varian Medical Systems, Inc.: Overview
Varian Medical Systems, Inc.: Key Facts
Varian Medical Systems, Inc.: Key Employees
Varian Medical Systems, Inc.: Key Employee Biographies
Varian Medical Systems, Inc.: Major Products and Services
Varian Medical Systems, Inc.: Company History
Varian Medical Systems, Inc.: Management Statement
Varian Medical Systems, Inc.: Key Competitors
Varian Medical Systems, Inc.: Company Analysis
Varian Medical Systems, Inc.: Business Description
Varian Medical Systems, Inc.: SWOT Analysis
Varian Medical Systems, Inc.: SWOT Overview
Varian Medical Systems, Inc.: Strengths
Varian Medical Systems, Inc.: Weaknesses
Varian Medical Systems, Inc.: Opportunities
Varian Medical Systems, Inc.: Threats
Varian Medical Systems, Inc.: Corporate Financial Deals Activity
Varian Medical Systems, Inc.: Financial Deals Overview
Varian Medical Systems, Inc.: Targets and Partners
Varian Medical Systems, Inc.: Top Deals 2013 – 2017YTD*
Varian Medical Systems, Inc.: Mergers and Acquisitions
Varian Medical Systems, Inc.: Partnership
Varian Medical Systems, Inc.: Recent Developments
Varian Medical Systems, Inc.: News and Events Summary
Varian Medical Systems, Inc.: Business Expansion
Varian Medical Systems, Inc.: Contracts
Varian Medical Systems, Inc.: Financial Performance
Varian Medical Systems, Inc.: Research & Development
Varian Medical Systems, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Varian Medical Systems, Inc.: Key Facts
Table 2: Varian Medical Systems, Inc.: Key Employees
Table 3: Varian Medical Systems, Inc.: Key Competitors
Table 4: Varian Medical Systems, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Varian Medical Systems, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Varian Medical Systems, Inc.: M&A Average Deal Size - Value (US$m)
Table 7: Varian Medical Systems, Inc.: Targets and Partners
Table 8: Varian Medical Systems, Inc.: Top Deals 2013 - 2017YTD*
Table 9: Varian Medical Systems, Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: Varian Medical Systems, Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 11: Varian Medical Systems, Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 12: Varian Medical Systems, Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 13: Varian Medical Systems, Inc.: News and Events Summary
Table 14: Varian Medical Systems, Inc.: Business Expansion
Table 15: Varian Medical Systems, Inc.: Contracts
Table 16: Varian Medical Systems, Inc.: Financial Performance
Table 17: Varian Medical Systems, Inc.: Research & Development
Table 18: Varian Medical Systems, Inc.: Strategy and Operations

★海外企業調査レポート[Varian Medical Systems, Inc.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Burmeister & Wain Scandinavian Contractor AS:企業の戦略的SWOT分析
    Burmeister & Wain Scandinavian Contractor AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Rohde & Schwarz GmbH & Co. KG:企業の戦略・SWOT・財務情報
    Rohde & Schwarz GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Rohde & Schwarz GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Blackbird Energy Inc (BBI):企業の財務・戦略的SWOT分析
    Summary Blackbird Energy Inc (Blackbird Energy), formerly Blackbird Investments Inc, is an independent oil and gas exploration and development company that acquires, explores, produces and develops oil and gas properties in Western Canada. The company holds interests in Elmworth Project which concen …
  • GFI Informatique (GFI):企業の財務・戦略的SWOT分析
    GFI Informatique (GFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • HIL Limited (HIL):企業の財務・戦略的SWOT分析
    HIL Limited (HIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lantheus Medical Imaging Inc-医療機器分野:企業M&A・提携分析
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • Zogenix Inc (ZGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Zogenix Inc (Zogenix) is a pharmaceutical company with focus on central nervous system (CNS) disorders. It develops and commercializes therapies for rare CNS disorders. The company’s lead product candidate ZX008 (low dose fenfluramine) is intended for the treatment of Dravet syndrome and Len …
  • Sarovar Hotels Private Ltd:企業の戦略・SWOT・財務分析
    Sarovar Hotels Private Ltd - Strategy, SWOT and Corporate Finance Report Summary Sarovar Hotels Private Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Carnival Corporation & plc:企業の戦略・SWOT・財務情報
    Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report Summary Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Rohol-Aufsuchungs Aktiengesellschaft:石油・ガス:M&Aディール及び事業提携情報
    Summary Rohol-Aufsuchungs Aktiengesellschaft (RAG) is an oil and gas company. The company operates in oil and gas exploration, production and trading; and gas storage. It produces crude oil and natural gas. RAG offers services such as renewable energy projects development and crude oil stockpiling a …
  • Grupo Bimbo S.A. de C.V.:企業の戦略・SWOT・財務情報
    Grupo Bimbo S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Bimbo S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ensign Energy Services Inc (ESI):企業の財務・戦略的SWOT分析
    Summary Ensign Energy Services Inc (Ensign Energy) is an oil and gas company that offers oilfield services. The company’s services include directional drilling, horizontal drilling, well servicing and testing services. It provides well completions and recompletions, abandonment of redundant wells, s …
  • Salesforce.Com Inc (CRM):企業の財務・戦略的SWOT分析
    Salesforce.Com Inc (CRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Alnylam Pharmaceuticals Inc (ALNY):企業の財務・戦略的SWOT分析
    Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Alnylam Pharmaceuticals Inc (ALNY):医療機器:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • Sprott Resource Holdings Inc. (SRHI):企業の財務・戦略的SWOT分析
    Sprott Resource Holdings Inc. (SRHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Airports of Thailand Plc (AOT):企業の財務・戦略的SWOT分析
    Airports of Thailand Plc (AOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nanion Technologies GmbH-医療機器分野:企業M&A・提携分析
    Summary Nanion Technologies GmbH (Nanion) is a biotechnology company that develops new innovations in the field of ion channel research and screening. The company offers products such as port-a-patch, patchliner, syncropatch 96, syncropatch 384pe, npc-chips, vesicle prep pro, ordering information, s …
  • Cellestia Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellestia Biotech AG (Cellestia Biotech) is a biopharmaceutical company that develops anti-cancer drugs for the treatment of oncology and immunological disorders. The company's lead compound includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymp …
  • Datang International Power Generation Co Ltd (991):企業の財務・戦略的SWOT分析
    Datang International Power Generation Co Ltd (991) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆